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Cytotoxic T lymphocyte (CTL) senescence may be an important mechanism of immune failure in HIV-1 infection. We find that
senescence of HIV-1-specific CTL clones causes loss of killing activity, preventable by transduction with telomerase. Furthermore,
senescence is associated with reduced expression of the effector molecules granzyme and perforin, suggesting CTL bexhaustionQ can result in
hypofunction. These results agree with other studies showing that HIV-1-specific CTL exhibit abnormal phenotypes in vivo, and suggest the
possibility that chronic turnover is an important mechanism of antiviral failure in HIV-1 infection.
D 2004 Elsevier Inc. All rights reserved.
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The CD8+ T lymphocyte compartment is markedly
perturbed compared to CD4+ T lymphocytes in HIV-1
infection (Effros et al., 1996; Wolthers et al., 1996), which
is counterintuitive in light of the tropism of HIV-1 for CD4+
cells. CD8+ cytotoxic T lymphocytes (CTL) are believed to
play a crucial role in suppressing the virus in vivo (Yang,
2003), and these cells likely proliferate constantly in the
presence of ongoing viral replication during chronic infec-
tion. Clonal exhaustion, or replicative senescence, due to
chronic proliferation therefore has been proposed as poten-
tially important mechanism of immune failure. While the
effects of senescence on cellular proliferative capacity,0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: oyang@mednet.ucla.edu (O.O. Yang).including lymphocytes (Hooijberg et al., 2000; Rufer et al.,
2001), have been well established, the impact on cellular
function remains less well understood. Here we evaluate a
mechanism of dysfunction in HIV-1-specific CTL clones by
preventing senescence by telomerase transduction.Results
Loss of cytolytic function due to senescence of
HIV-1-specific CTL
To evaluate the impact of senescence, HIV-1-specific
CTL clones were transduced with hTERT, allowing cons-
titutive expression of telomerase. Consistent with the known
activity of telomerase to delay senescence and preserve
replicative capacity of lymphocytes (Hooijberg et al., 2000;
Rufer et al., 2001), the hTERT-transduced clones expanded
more efficiently than the vector-transduced negative controls005) 16–19
Fig. 1. Killing activity of hTERT transduced and nontransduced HIV-1-
specific CTL. HIV-1-specific clones 68A62 and 1.3.23 were utilized in
standard chromium release assays (effector to target ratio of 5:1) using the
HLA A*0201-expressing cell line T1 pulsed with the appropriate synthetic
peptide. Clone 68A62 had been passaged for 12 weekly passages after
hTERT transduction, and 1.3.23-SL9 for 10 weekly passages.
Rapid Communication 17after multiple passages [demonstrated for clone 68A62 in
Dagarag et al. (2003) and data not shown]. When the
passaged CTL clones were assessed for killing capacity
against peptide-pulsed target cells in chromium release
assays, the nontransduced CTL were found to have lost
killing activity, while the hTERT-transduced CTL retained
the ability to kill efficiently (Fig. 1). At effector/target cellFig. 2. Perforin and granzyme expression in hTERT transduced and nontransduce
intracellular perforin and granzyme B measurement by flow cytometric analysis.
intensities of specific staining (above isotype control staining) are plotted for (C)(E/T) ratios of 5:1 or less, the nontransduced clones
mediated specific lysis of 3% or less. In contrast, the same
clones that had been transduced by hTERT retained efficient
cytolytic capacity, mediating about 80% specific lysis at an
E:T ratio of 5:1. Thus, there was a striking discrepancy in
the ability of CTL to kill in the presence or absence of
constitutive hTERT expression, in agreement with prior
results with HIV-1-specific CTL (Dagarag et al., 2003).
Reduced perforin and granzyme B expression in senescent
HIV-1-specific CTL
The perforin–granzyme pathway has been shown to be
the major mechanism of killing by HIV-1-specific CTL
(Shankar et al., 1999). The hTERT-transduced and non-
transduced clones were therefore evaluated for expression of
perforin and granzyme B, to evaluate whether altered levels
might be responsible for differential killing activity (Fig. 2).
Intracellular staining for perforin demonstrated nearly
undetectable levels in the nontransduced cells, and weakly
detectable levels in the hTERT-transduced cells. Staining for
granzyme B revealed moderate staining of nontransduced
cells, but clearly more intense staining of hTERT-transduced
cells. The delay of senescence by hTERT transduction wasd HIV-1-specific CTL. The same clones utilized in Fig. 1 were stained for
(A, B) Dot plots of clone 68A62 staining are shown. Mean fluorescence
perforin and (D) granzyme B.
Rapid Communication18therefore associated with reduced perforin and granzyme B
expression, in addition to loss of cytolytic capacity.Discussion
These data suggest a mechanism for our prior observa-
tion that telomerase transduction prevents the selective loss
of cytolytic function but not interferon-gamma production
by senescent HIV-1-specific CTL clones (Dagarag et al.,
2003). In the context of results showing extensive turnover
and telomere shortening in the CD8+ T lymphocyte
compartment of HIV-1-infected individuals, these findings
imply a functional derangement of CD8+ effector T
lymphocytes. Although the precise mechanisms whereby
CTL suppress HIV-1 in vivo remain unknown, in vitro
experiments have indicated that cytolytic function is a
crucial component (Yang et al., 1997). Loss of CTL killing
potential due to senescence therefore could contribute to
ineffectiveness of cellular immunity in vivo. In support of
this hypothesis, Migueles et al. (2002) have reported that
perforin expression and proliferative capacity are associated
with long-term nonprogression in HIV-1-infected persons.
CTL function is likely to be an important aspect when
analyzing the response to HIV-1 infection (Yang, 2003).
Global measurements of CTL frequency or breadth have
indicated that the antiviral activity of CTL in vivo is not a
simple quantitative function (Addo et al., 2003; Betts et al.,
2001). It is probable that this interaction has multiple
complex determinants, including the efficiency of infected
cell recognition due to epitope targeting (Yang et al.,
2003b), the ability of HIV-1 to escape through epitope
mutation (Yang et al., 2003a), and the function of CTL after
being triggered to recognize an infected cell. Addressing
such factors may be crucial to the success of immune-based
therapies for HIV-1 infection.Materials and methods
HIV-1-specific CTL clones
HIV-1-specific CTL clones were obtained from the blood
of infected persons through limiting dilution cloning, and
maintained in tissue culture with periodic restimulations
using anti-CD3 antibody and irradiated allogeneic feeder
PBMC, as previously reported (Yang et al., 1996, 1997).
Clones 68A62 and 1.3.23 recognized the HLA A*0201-
restricted epitopes ILKEPGHGV (RT a.a. 309–317 num-
bered according to the HXB2 sequence) and SLYNTVATL
(Gag p17 a.a. 77–85), respectively.
Transduction of CTL with telomerase
The clones were transduced using a viral transduction
vector generated from stably transfected PA317 packagingcells provided by Geron Corporation (Menlo Park, CA), as
previous described (Dagarag et al., 2003).
Chromium release assays
Transduced and nontransduced CTL clones were screened
for lytic activity by standard chromium release assays using
T1 cells (expressing A*0201) labeled with excess cognate
peptides, as previously described (Yang et al., 1996).
Flow cytometric analysis of perforin and granzyme
B expression
Transduced and nontransduced CTL clones were stained
for intracellular perforin (FITC conjugated antibody from
Ancell Corporation, Bayport, MN) and granzyme B (PE
conjugated antibody from Research Diagnostics, Flanders,
NJ) after permeabilization (Becton Dickinson), and eva-
luated by flow cytometric analysis.Acknowledgments
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